Pacific Biosciences Of California reported $-35.4M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Agilent USD 456M 84M Dec/2025
Bruker USD 110M 101.6M Mar/2026
Danaher USD 1.92B 204M Mar/2026
General Electric Aerospace USD 2.84B 568M Mar/2026
Illumina USD 469M 137M Dec/2025
Myriad Genetics USD 14.3M 4M Dec/2025
Pacific Biosciences Of California USD -35.4M 5.78M Sep/2025
Quidel USD 108.7M 44.6M Mar/2026
Revvity USD 272.91M 24M Mar/2026
Roche Holding CHF 12.68B 2.36B Jun/2024
Standard Biotools USD -15.81M 734K Dec/2025
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Waters USD 380.97M 85.83M Dec/2025